Article
12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers

  • Edesa Biotech (NASDAQ:EDSA) shares rose 74.1% to $1.56 during Tuesday's regular session. The market value of their outstanding shares is at $7.5 million.
  • BioRestorative Therapies (NASDAQ:BRTX) shares rose 52.71% to $0.3. The company's market cap stands at $4.5 million.
  • Palvella Therapeutics (NASDAQ:PVLA) stock moved upwards by 32.81% to $116.67. The market value of their outstanding shares is at $1.0 billion.
  • Larimar Therapeutics (NASDAQ:LRMR) shares increased by 32.63% to $3.73. The company's market cap stands at $233.4 million.
  • Iovance Biotherapeutics (NASDAQ:IOVA) stock moved upwards by 30.24% to $3.76. The company's market cap stands at $1.0 billion. The company's, Q4 earnings came out today.
  • Vir Biotechnology (NASDAQ:VIR) shares moved upwards by 29.04% to $9.59. The market value of their outstanding shares is at $1.0 billion. The company's, Q4 earnings came out yesterday.

Losers

  • Claritev (NYSE:CTEV) shares fell 41.4% to $13.62 during Tuesday's regular session. The company's market cap stands at $383.8 million. As per the press release, Q4 earnings came out yesterday.
  • Protara Therapeutics (NASDAQ:TARA) stock fell 21.27% to $5.85. The company's market cap stands at $398.1 million.
  • Fulcrum Therapeutics (NASDAQ:FULC) stock decreased by 14.15% to $9.35. The company's market cap stands at $718.4 million. As per the press release, Q4 earnings came out today.
  • AdaptHealth (NASDAQ:AHCO) shares decreased by 13.42% to $8.91. The market value of their outstanding shares is at $1.3 billion. The company's, Q4 earnings came out today.
  • 20/20 Biolabs (NASDAQ:AIDX) stock declined by 11.67% to $9.12. The company's market cap stands at $106.8 million.
  • Avanos Medical (NYSE:AVNS) stock fell 10.38% to $13.65. The company's market cap stands at $700.6 million. As per the news, the Q4 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments
  • No comments yet. Be the first to comment!